1. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995; 39:429–50.
Article
2. Basti S, Macsai MS. Ocular surface squamous neoplasia: A review. Cornea. 2003; 22:687–704.
3. Ateenyi-Agaba C. Conjunctival squamous-cell carcinoma asso-ciated with HIV infection in Kampala, Uganda. Lancet. 1995; 345:695–6.
Article
4. Waddell KM, Lewallen S, Lucas SB. . Carcinoma of the con-junctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol. 1996; 80:503–8.
Article
5. Porges Y, Groisman GM. Prevalence of HIV with conjunctival squamous cell neoplasia in an African provincial hospital. Cornea. 2003; 22:1–4.
Article
6. Goedert JJ, Coté TR. Conjunctival malignant disease with AIDS in USA. Lancet. 1995; 346:257–8.
Article
7. Guech-Ongey M, Engels EA, Goedert JJ. . Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States. Int J Cancer. 2008; 122:2590–3.
Article
8. Shields CL, Ramasubramanian A, Mellen PL, Shields JA. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection). Ophthalmology. 2011; 118:2133–7.e1.
Article
9. Mahomed A, Chetty R. Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia. Arch Ophthalmol. 2002; 120:554–8.
Article
10. Kao AA, Galor A, Karp CL. . Clinicopathologic correlation of ocular surface squamous neoplasms at bascom palmer eye in-stitute: 2001 to 2010. Ophthalmology. 2012; 119:1773–6.
Article
11. Poole TR. Conjunctival squamous cell carcinoma in Tanzania. Br J Ophthalmol. 1999; 83:177–9.
Article
12. Cheon HC, Lee DY, Park WC, Ahn HB. Ocular surface squamous neoplasia. Korean Ophthalmol Soc. 2006; 47:1920–8.